Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 2
2014 3
2015 3
2016 2
2017 3
2018 3
2019 1
2020 4
2021 3
2022 2
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
ALK, ROS1, RET and NTRK1-3 Gene Fusions in Colorectal and Non-Colorectal Microsatellite-Unstable Cancers.
Mulkidjan RS, Saitova ES, Preobrazhenskaya EV, Asadulaeva KA, Bubnov MG, Otradnova EA, Terina DM, Shulga SS, Martynenko DE, Semina MV, Belogubova EV, Tiurin VI, Amankwah PS, Martianov AS, Imyanitov EN. Mulkidjan RS, et al. Among authors: preobrazhenskaya ev. Int J Mol Sci. 2023 Sep 2;24(17):13610. doi: 10.3390/ijms241713610. Int J Mol Sci. 2023. PMID: 37686416 Free PMC article.
Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation.
Sokolenko A, Preobrazhenskaya E, Marchetti C, Piermattei A, Zagrebin F, Kuligina E, Gorodnova T, Pavone M, Ivantsov A, Bizin I, Scambia G, Berlev I, Fagotti A, Imyanitov E. Sokolenko A, et al. Among authors: preobrazhenskaya e. Pathobiology. 2024;91(2):108-113. doi: 10.1159/000533591. Epub 2023 Aug 14. Pathobiology. 2024. PMID: 37579727
Rapid and Cost-Efficient Detection of RET Rearrangements in a Large Consecutive Series of Lung Carcinomas.
Tiurin VI, Preobrazhenskaya EV, Mitiushkina NV, Romanko AA, Anuskina AA, Mulkidjan RS, Saitova ES, Krivosheyeva EA, Kharitonova ED, Shevyakov MP, Tryakin IA, Aleksakhina SN, Venina AR, Sokolova TN, Martianov AS, Shestakova AD, Ivantsov AO, Iyevleva AG, Imyanitov EN. Tiurin VI, et al. Among authors: preobrazhenskaya ev. Int J Mol Sci. 2023 Jun 23;24(13):10530. doi: 10.3390/ijms241310530. Int J Mol Sci. 2023. PMID: 37445709 Free PMC article.
Comprehensive evaluation of the test for 5'-/3'-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer.
Mitiushkina NV, Romanko AA, Preobrazhenskaya EV, Tiurin VI, Ermachenkova TI, Martianov AS, Mulkidjan RS, Sokolova TN, Kholmatov MM, Bizin IV, Ivantsov AO, Yatsuk OS, Zaitseva OA, Iyevleva AG, Kuligina ES, Imyanitov EN. Mitiushkina NV, et al. Among authors: preobrazhenskaya ev. Cancer Med. 2022 Sep;11(17):3226-3237. doi: 10.1002/cam4.4686. Epub 2022 Mar 23. Cancer Med. 2022. PMID: 35322575 Free PMC article.
Molecular predictors of the outcome of paclitaxel plus carboplatin neoadjuvant therapy in high-grade serous ovarian cancer patients.
Sokolenko AP, Gorodnova TV, Bizin IV, Kuligina ES, Kotiv KB, Romanko AA, Ermachenkova TI, Ivantsov AO, Preobrazhenskaya EV, Sokolova TN, Broyde RV, Imyanitov EN. Sokolenko AP, et al. Among authors: preobrazhenskaya ev. Cancer Chemother Pharmacol. 2021 Sep;88(3):439-450. doi: 10.1007/s00280-021-04301-6. Epub 2021 Jun 2. Cancer Chemother Pharmacol. 2021. PMID: 34080040
32 results